title: Ultra-high dose of mesalamine to treat steroid-dependent ulcerative colitis.
authors.affiliation: Division of Gastroenterology, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Canada.
authors.forename: Soleiman B
authors.initials: SB
authors.lastname: Kashkooli
authors.affiliation: Division of Gastroenterology, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Canada.
authors.forename: Mehrdad
authors.initials: M
authors.lastname: Rouhani
authors.affiliation: Division of Gastroenterology, Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Canada. Electronic address: fred.saibil@utoronto.ca.
authors.forename: Fred
authors.initials: F
authors.lastname: Saibil
mesh_terms: D000328:Adult; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage*; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D004305:Dose-Response Relationship, Drug; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D008297:Male; D019804:Mesalamine / Q000008:administration & dosage*; D011241:Prednisone / Q000627:therapeutic use
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D005938:Glucocorticoids; D019804:Mesalamine; D011241:Prednisone